Orthostatic Hypotension Management

Introduction

Orthostatic hypotension is a significant concern in diabetic patients due to autonomic neuropathy, with an increased risk of orthostatic hypotension 1

Dehydration decreases effective circulating blood volume, worsening orthostatic intolerance, according to the American College of Cardiology 2
Both dehydration and heat stress worsen orthostatic tolerance, as noted by the American College of Cardiology 2
Postprandial hypotension (PPH) is defined as a decrease in systolic blood pressure of ≥20 mmHg within 15 minutes to 2 hours after a meal, occurring in approximately 40% of nursing home residents, particularly in elderly patients, patients with diabetes mellitus, and patients with autonomic dysfunction 3

Orthostatic hypotension is defined as a decrease in systolic BP ≥20 mmHg or diastolic BP ≥10 mmHg, or decrease in systolic BP to <90 mmHg within 3 minutes of standing, with a specificity of 95% but sensitivity of 25% 4, 5

The American College of Cardiology recommends fluid resuscitation via oral or intravenous bolus for syncope due to acute dehydration (Class I, Level C-LD) 6, 7
Oral fluid bolus may require less volume than IV fluid to achieve similar effects due to its pressor effect, as reported by the American College of Cardiology 2
Midodrine is recommended as a first-line medication at a dose of 5-20mg three times daily (last dose at least 4 hours before bedtime) for symptomatic orthostatic hypotension refractory to non-pharmacological measures, with a strength of evidence level of I (high-quality evidence) 5

The following medications are recommended for dysautonomia management:

Medication	Dosing Range	Indication
Fludrocortisone	0.1mg daily	Neurogenic orthostatic hypotension
Midodrine	5-20mg three times daily	Symptomatic orthostatic hypotension refractory to non-pharmacological measures
Droxidopa	100-600mg three times daily	Neurogenic orthostatic hypotension
Pyridostigmine	30mg 2-3 times daily	Orthostatic hypotension refractory to other treatments
Octreotide	-	Refractory recurrent postprandial or neurogenic orthostatic hypotension
Acarbose	-	Postprandial hypotension, particularly in patients with autonomic dysfunction
Beta-blockers (e.g., metoprolol, nebivolol, or bisoprolol)	-	Resting tachycardia in patients with dysautonomia, with a strength of evidence level of II (moderate-quality evidence) [4, 5]

The first-line treatment for dysautonomia should focus on non-pharmacological measures, including elevating the head of bed by 10°, optimizing compression stockings, physical counterpressure maneuvers, and adequate salt/fluid intake, as suggested by the American Heart Association 4, 5
It is reasonable to encourage increased salt and fluid intake in selected patients with dehydration-related symptoms (Class IIa, Level C-LD), according to the American College of Cardiology 2, 6
Higher-sodium-content beverages with osmolality comparable to normal body osmolality rehydrate faster than lower-sodium-content beverages, as found by the American College of Cardiology 2

Diabetic patients should focus on glucose control alongside orthostatic management, and be monitored closely for orthostatic hypotension due to increased risk, as recommended by the American Diabetes Association 5, 8, 9, 10
Heart failure patients should use volume-expanding agents cautiously, and be monitored closely for signs of volume overload, as recommended by the American Heart Association 5, 8, 6
Pregnant patients should prioritize volume expansion with intravenous fluids for acute management, and position change to left lateral decubitus position for symptomatic episodes, with a strength of evidence level of III (low-quality evidence) 11
Elderly patients should start with lower medication doses and be monitored closely for signs of orthostatic hypotension, with a strength of evidence level of II (moderate-quality evidence) 12
Patients with renal impairment should start with a 2.5 mg dose of midodrine and be monitored closely, with a strength of evidence level of II (moderate-quality evidence) 5
Patients with supine hypertension should be monitored closely, with blood pressure measured in both supine and standing positions, and the final daily dose administered at least 4 hours before bedtime, with a strength of evidence level of II (moderate-quality evidence) 9

Regular weight assessment and electrolyte monitoring, particularly with fludrocortisone, are recommended to ensure effective management of orthostatic hypotension, with a strength of evidence level of II (moderate-quality evidence) 12
Assessing continued effectiveness of treatment periodically is crucial to adjust the management plan as needed, with a strength of evidence level of II (moderate-quality evidence) 12
Daily weight assessment and regular electrolyte monitoring, particularly potassium and sodium, are essential to evaluate fluid status and treatment efficacy, with a strength of evidence level of II (moderate-quality evidence) 4, 13
Heart rate monitoring during position changes can help assess improvement in symptoms, with a strength of evidence level of II (moderate-quality evidence) 5
A symptom diary can help track frequency and severity of symptoms, with a strength of evidence level of II (moderate-quality evidence) 5

Failing to test for orthostatic hypotension before starting or intensifying blood pressure-lowering medication can lead to adverse outcomes, with a strength of evidence level of II (moderate-quality evidence) 12
Overlooking orthostatic hypotension as a cause of falls in elderly patients can result in inadequate management, with a strength of evidence level of II (moderate-quality evidence) 14
Focusing on BP numbers rather than symptom improvement is a common pitfall in orthostatic hypotension management, with a strength of evidence level of II (moderate-quality evidence) 12
Overlooking non-pharmacological measures before starting medications is a common mistake that can lead to ineffective management of orthostatic hypotension, with a strength of evidence level of II (moderate-quality evidence) 12
Improper timing of medications, such as administering vasopressors too close to bedtime, can worsen orthostatic hypotension, with a strength of evidence level of II (moderate-quality evidence) 12
Inadequate monitoring for supine hypertension can lead to serious complications, with a strength of evidence level of II (moderate-quality evidence) 12
Failure to switch BP-lowering medications that worsen orthostatic hypotension to alternative therapies can lead to ineffective management of orthostatic hypotension, with a strength of evidence level of II (moderate-quality evidence) 12